AI assistant
Vericel Corp — Director's Dealing 2011
Mar 4, 2011
31799_dirs_2011-03-04_cc92a4a5-1209-445e-b443-dbb238251819.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2011-03-02
Reporting Person: MAYLEBEN TIMOTHY M (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-02 | Common Stock | P | 6550 | $2.089 | Acquired | 88168 | Direct |
| 2011-03-03 | Common Stock | P | 14832 | $2.136 | Acquired | 103000 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.08 to $2.09, inclusive. The reporting person undertakes to provide to Aastrom Biosciences, Inc., any security holder of Aastrom Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2).
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.13 to $2.15, inclusive.